All News #Library
Others
Spyglass Pharma Reports Q4, Full-Year 2025 Earnings Update
26 Mar 2026 //
GLOBENEWSWIRE
Spyglass Pharma Joins Jefferies Biotech Summit
04 Mar 2026 //
GLOBENEWSWIRE
SpyGlass Pharma Announces Pricing Of Initial Public Offering
05 Feb 2026 //
GLOBENEWSWIRE
Spyglass Pharma Names Jean-Frédéric Viret As CFO
06 Jan 2026 //
GLOBENEWSWIRE
Spyglass Pharma Reveals Positive Glaucoma Therapy Trial Results
14 Nov 2025 //
INDPHARMAPOST
Spyglass Pharma`s BIM-IOL System Shows Significant Mean IOP
14 Oct 2025 //
GLOBENEWSWIRE
SpyGlass Pharma Names Anand Sundaram as Commercial Head
16 Sep 2025 //
GLOBENEWSWIRE
Elizabeth O’Farrell Joins SpyGlass Pharma Board of Directors
19 Aug 2025 //
GLOBENEWSWIRE
SpyGlass Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform
02 Apr 2024 //
GLOBENEWSWIRE
SpyGlass Strengthens Leadership to Advance Intraocular Drug Delivery Platform
05 Dec 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support